Core Viewpoint - The company is focused on the diabetes treatment sector, leveraging a differentiated research and development strategy to build its product pipeline [1] Group 1: Company Strategy - The company emphasizes its commitment to the diabetes treatment field, indicating a deep understanding of the market and patient needs [1] - The company’s product positioning, target mechanisms, and clinical data provide unique advantages in the competitive landscape [1] Group 2: Market Opportunity - There is a large and diverse patient base for diabetes in China, creating significant opportunities for various mechanism products to complement each other [1] - The company plans to continue advancing clinical progress and commercial layout to meet the diverse needs of diabetes patients [1]